About this trial
This is a multinational, prospective, observational study designed to characterize patient demographics, prescription parameters, and process measures of continuous renal replacement therapy (CRRT) in intensive care units (ICUs) worldwide. The study aims to examine similarities and differences in CRRT practices and outcomes among critically ill adult patients across a global network of medical centers.
The goal is to develop a large, comprehensive repository of data on CRRT practices and outcomes. This repository will enable characterization of variation in standard CRRT practices across medical centers. Natural variability in practice patterns-both between and within centers-will provide an opportunity to compare outcomes associated with different approaches and to generate high-quality preliminary data to inform future interventional trials.
Primary Objective
\- To describe global patient characteristics, CRRT modalities, and clinical outcomes among patients receiving CRRT.
Secondary Objectives
* To compare clinical outcomes across geographic regions and CRRT modalities. * To identify patient-level and practice-level predictors of outcomes. * To assess the impact of comorbid conditions (e.g., diabetes mellitus) on CRRT outcomes.
Exploratory Objectives
* To evaluate long-term renal outcomes and patient-reported quality of life. * To explore health economics and resource utilization related to CRRT.
Study Population All patients receiving CRRT as part of routine clinical care in the ICU at participating centers will be eligible for inclusion.
Data Collection The study will support an epidemiological assessment of patients undergoing CRRT, including, but not limited to, demographics, underlying disease states, severity of illness, physiological support, indications for CRRT, and clinical outcomes. Outcomes of interest include ICU and hospital mortality, ICU and hospital length of stay, and renal recovery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Admission to an intensive care unit
CRRT therapy
Disqualifiers
End-stage kidney disease
CRRT <24 hours
Trial population
Patients with new acute kidney injury and initiation of continuous renal replacement therapy who are admitted to an intensive care unit and who have received continuous renal replacement therapy for at least 24 hours will be eligible for this study.
Trial design
Cohort
Prospective
Treatments tested in this trial
continuous renal replacement therapy
DeviceWe will include any critically ill patient admitted to an intensive care unit requiring dialysis
Treatment groups
Trial outcomes
Primary outcomes
Mortality
Patient survival at the time of ICU discharge
Secondary outcomes
Hospital mortality
Patient survival status during their hospitalization
ICU length of stay
Duration of ICU stay
Hospital length of Stay
Duration of hospital stay
Renal recovery
1\) Return of serum creatinine (SCr) to within 50% of baseline; 2) no longer receiving dialysis
Other outcomes
Health Related Quality of Life
Health Related Quality of Life (EQ-5D-5L) "EuroQol 5-Dimension 5-Level" questionnaire.
Health Economic Analysis
ICU and Hospital Costs
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Alberta
Lead sponsor
University of Alabama at Birmingham
Collaborator
University of Zagreb
Collaborator
This trial is not recruiting at the moment. You can still explore other options: